74 results
6-K
EX-10.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
Statement and the Prospectus. To the knowledge of the Company, such accountants are independent public accountants as required by Canadian Securities … ) and are an independent registered public accounting firm within the meaning of the Securities Act and the applicable rules and regulations thereunder
6-K
EX-5.1
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Current report (foreign)
5:29pm
and have not performed any independent check or verification of such factual matters.
In giving this opinion, we have assumed the genuineness of all
424B5
IPA
ImmunoPrecise Antibodies Ltd
23 Feb 24
Prospectus supplement for primary offering
5:26pm
is not guaranteed and has not been verified by any independent sources. Market and industry data, including estimates and projections relating to size of market … 1400, Minneapolis, MN 55402. Grant Thornton LLP is independent from the Company within the meaning of the rules of professional conduct of the Chartered
6-K
EX-99.1
IPA
ImmunoPrecise Antibodies Ltd
14 Dec 23
Immunoprecise Antibodies LTD. 6-K
8:03am
to conduct an independent review of the asset under contemplation of an out-licensing. Simultaneously, the Company's marketing partnerships are enhancing
424B5
IPA
ImmunoPrecise Antibodies Ltd
7 Dec 23
Prospectus supplement for primary offering
4:53pm
and forecasts that are based on independent industry publications and other publicly available information. Although we believe these sources are reliable … is not guaranteed and has not been verified by any independent sources. Market and industry data, including estimates and projections relating to size of market
6-K
EX-8.1
cpje9wt8t2 yg
6 Dec 23
Current report (foreign)
5:19pm
6-K
EX-5.1
erm24e55pdr
6 Dec 23
Current report (foreign)
5:19pm
6-K
EX-10.1
mukbq7 vjnsq4f
6 Dec 23
Current report (foreign)
5:19pm
424B5
83my2f4q6 mpa
5 Dec 23
Prospectus supplement for primary offering
4:02pm
6-K
EX-99.1
r6mgge7rt
20 Oct 23
Current report (foreign)
2:56pm
6-K
EX-99.1
nc5g72re34s9
18 Sep 23
Statement of Executive Compensation
2:47pm
6-K
EX-99.1
p78j7xu wdoxxd6riq
12 Sep 23
Material Change Report
6:20pm
6-K
EX-99.1
x4p15
5 Sep 23
IPA appoints Barry A. Springer, Dirk Witters and Chris Buyse to the Board of Directors
8:14am
6-K
EX-10.1
5hgurfm6b ke
15 Aug 23
Current report (foreign)
5:50pm
424B5
wzj2z7 3ss
15 Aug 23
Prospectus supplement for primary offering
5:47pm
F-3
4py9nuot5gg5pgv
10 Jul 23
Shelf registration (foreign)
7:04pm
F-3
EX-23.2
6iwqwi dj4rztb
10 Jul 23
Shelf registration (foreign)
7:04pm
F-3
EX-4.3
uhhgyf
10 Jul 23
Shelf registration (foreign)
7:04pm
40-F
EX-99.2
qlsuls0im87jf0
10 Jul 23
Annual report (Canada)
4:32pm
40-F
EX-99.1
6oqp5
10 Jul 23
Annual report (Canada)
4:32pm